A new study led by researchers at Columbia University indicates that patients who receive methadone take-home doses—a protocol expanded during the COVID pandemic—are no more likely to overdose or drop out of care than those whose methadone is delivered at government‐approved opioid treatment programs.
Read full article: https://www.columbiapsychiatry.org/news/study-no-spike-overdose-deaths-covid-era-expansion-methadone-access
0 Comments